Literature DB >> 14990596

Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).

G M-K Tse1, K-F To, P K-S Chan, A W I Lo, K-C Ng, A Wu, N Lee, H-C Wong, S-M Mak, K-F Chan, D S C Hui, J J-Y Sung, H-K Ng.   

Abstract

BACKGROUND: Severe acute respiratory syndrome (SARS) became a worldwide outbreak with a mortality of 9.2%. This new human emergent infectious disease is dominated by severe lower respiratory illness and is aetiologically linked to a new coronavirus (SARS-CoV).
METHODS: Pulmonary pathology and clinical correlates were investigated in seven patients who died of SARS in whom there was a strong epidemiological link. Investigations include a review of clinical features, morphological assessment, histochemical and immunohistochemical stainings, ultrastructural study, and virological investigations in postmortem tissue.
RESULTS: Positive viral culture for coronavirus was detected in most premortem nasopharyngeal aspirate specimens (five of six) and postmortem lung tissues (two of seven). Viral particles, consistent with coronavirus, could be detected in lung pneumocytes in most of the patients. These features suggested that pneumocytes are probably the primary target of infection. The pathological features were dominated by diffuse alveolar damage, with the presence of multinucleated pneumocytes. Fibrogranulation tissue proliferation in small airways and airspaces (bronchiolitis obliterans organising pneumonia-like lesions) in subpleural locations was also seen in some patients.
CONCLUSIONS: Viable SARS-CoV could be isolated from postmortem tissues. Postmortem examination allows tissue to be sampled for virological investigations and ultrastructural examination, and when coupled with the appropriate lung morphological changes, is valuable to confirm the diagnosis of SARS-CoV, particularly in clinically unapparent or suspicious but unconfirmed cases.

Entities:  

Mesh:

Year:  2004        PMID: 14990596      PMCID: PMC1770245          DOI: 10.1136/jcp.2003.013276

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Update: outbreak of severe acute respiratory syndrome--worldwide, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-04       Impact factor: 17.586

3.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

4.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

5.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  Identification of severe acute respiratory syndrome in Canada.

Authors:  Susan M Poutanen; Donald E Low; Bonnie Henry; Sandy Finkelstein; David Rose; Karen Green; Raymond Tellier; Ryan Draker; Dena Adachi; Melissa Ayers; Adrienne K Chan; Danuta M Skowronski; Irving Salit; Andrew E Simor; Arthur S Slutsky; Patrick W Doyle; Mel Krajden; Martin Petric; Robert C Brunham; Allison J McGeer
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

Review 7.  Bronchiolitis obliterans organizing pneumonia.

Authors:  G R Epler
Journal:  Arch Intern Med       Date:  2001-01-22

8.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

9.  Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer.

Authors:  R J Folz; M A Elkordy
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

10.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China.

Authors:  Yanqing Ding; Huijun Wang; Hong Shen; Zhuguo Li; Jian Geng; Huixia Han; Junjie Cai; Xin Li; Wei Kang; Desheng Weng; Yaodan Lu; Dehua Wu; Li He; Kaitai Yao
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

View more
  111 in total

1.  Sputum cytology of patients with severe acute respiratory syndrome (SARS).

Authors:  G M K Tse; P-K Hui; T K F Ma; A W I Lo; K-F To; W Y Chan; L T C Chow; H-K Ng
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

2.  Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

Authors:  Shutoku Matsuyama; Makoto Ujike; Shigeru Morikawa; Masato Tashiro; Fumihiro Taguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

3.  Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens.

Authors:  D T M Leung; W W C van Maren; F K L Chan; W S Chan; A W I Lo; C H Ma; F C H Tam; K F To; P K S Chan; J J Y Sung; P L Lim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients.

Authors:  S C S Chow; C Y S Ho; T T Y Tam; C Wu; T Cheung; P K S Chan; M H L Ng; P K Hui; H K Ng; D M Y Au; A W I Lo
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

5.  Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study.

Authors:  Cheng Chen; Wei Sun; Jun Chen; Jian-An Huang
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

6.  Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors.

Authors:  D S Hui; G M Joynt; K T Wong; C D Gomersall; T S Li; G Antonio; F W Ko; M C Chan; D P Chan; M W Tong; T H Rainer; A T Ahuja; C S Cockram; J J Y Sung
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

7.  Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus.

Authors:  Zhaohui Qian; Emily A Travanty; Lauren Oko; Karen Edeen; Andrew Berglund; Jieru Wang; Yoko Ito; Kathryn V Holmes; Robert J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

8.  Enhancement of SARS-CoV infection by proteases.

Authors:  Shutoku Matsuyama; Makoto Ujike; Koji Ishii; Shuetsu Fukushi; Shigeru Morikawa; Masato Tashiro; Fumihiro Taguchi
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

9.  Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.

Authors:  Robert J Hogan; Guangping Gao; Thomas Rowe; Peter Bell; Douglas Flieder; Jason Paragas; Gary P Kobinger; Nelson A Wivel; Ronald G Crystal; Julie Boyer; Heinz Feldmann; Thomas G Voss; James M Wilson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus.

Authors:  Kwonil Jung; Konstantin P Alekseev; Xinsheng Zhang; Doo-Sung Cheon; Anastasia N Vlasova; Linda J Saif
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.